Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?
Frost & Sullivan
MARCH 22, 2024
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% growth from 2023 to 2024. What is driving transformation in the pharma industry? How are drug discovery companies enhancing R&D and accelerating growth through ecosystem partnerships?
Let's personalize your content